Pharma
Filter By: News | Articles | Products | Posters | White Papers | Videos | Podcasts | Application Notes | Journal Articles
Fine Tuning Treatments for Depression
Oct 19 | News
New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated – a finding that may help fine-tune therapies for depression.
A Flash of Inspiration
Oct 13 | Bioscience Technology Blog
According to IBM, DNA origami causes single DNA molecules to self assemble in solution via a reaction between a long single strand of viral DNA and a mixture of different short synthetic oligonucleotide strands.
They Like Me, They Like Me Not
Oct 13 | Bioscience Technology Blog
It should come as no surprise to you all that your profession—science—is highly respected by the general public. I’m sure many of you expected this, but now there is validation in the form of a survey conducted by The Pew Research Center for the People and the Press.
Why We Do What We Do
Oct 13 | Bioscience Technology Blog
Our industry is unique in that it is often only limited by the imagination of those working in it. If you can think of it and find funding (which often presents its own difficulties), then you can work on it.
Biochemists Prolong the Half-life of Pharmacological Substances
Sep 22 | News
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body.
RNAi Found in Budding Yeasts
Sep 15 | News
RNAi, a key biochemical pathway in the genetic control networks of most organisms, has now been discovered in Saccharomyces castellii, a close relative of the prototypical budding yeast S. cerevisiae, and in Candida albicans, a common human pathogen.
Boron-based Compounds Trick a Biomedical Protein
Sep 2 | News
Chemists and biologists have successfully demonstrated that specially synthesized boron compounds are readily accepted in biologically active enzymes, a move that, they say, is a proof of concept that could lead to new drug design strategies.
Marine Microbes Creating Green Waves in Industry
Aug 7 | News
New technology designed to analyze large numbers of novel marine microbes could lead to more efficient and greener ways to manufacture new drugs for conditions such as epilepsy, diabetes, flu, and other viruses, as well as improving the manufacture of other products such as agrochemicals.